Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
NCT Number: NCT03600038
The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98109, United States
Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.
The control intervention uses a standard of care smartphone smoking cessation app.
Time frame: 2 months post randomization
No smoking in the past 30 days, as reported 2 months post treatment.
Fred Hutchinson Cancer Center
Other
Pilot Trial of a Smartphone Smoking Cessation Application Intervention for Cancer Patients (Quit2Heal Study)
Acronym: Quit2Heal
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01673243
Anemia, Anemia, Hemolytic
Memphis, Tennessee, United States
View Trial DetailsNCT05643469
Behavior, Cancer
Hong Kong
View Trial DetailsNCT04620915
Behavior, Cancer
Eugene, Oregon, United States
View Trial DetailsNCT04738643
Behavior, Cancer
Philadelphia, Pennsylvania, United States
View Trial Details